Biomarker based therapies in high risk cancer patients - MACC1 as molecular target
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Berlin, Humboldt-Universität zu Berlin, Dissertation, 2019
- Keyword
-
Cancer--Patients
Risk
- Event
-
Veröffentlichung
- (where)
-
Berlin
- (who)
-
Humboldt-Universität zu Berlin
- (when)
-
2020
- Creator
- Contributor
-
Stein, Ulrike
Klipp, Edda
Feller, Stephan Michael
- DOI
-
10.18452/21021
- URN
-
urn:nbn:de:kobv:11-110-18452/21784-4
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:56 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zincke, Fabian
- Stein, Ulrike
- Klipp, Edda
- Feller, Stephan Michael
- Humboldt-Universität zu Berlin
Time of origin
- 2020
Other Objects (12)
Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies
Adjuvant therapies of cancer
Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients
Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients
Update breast cancer 2020 part 5: moving therapies from advanced to early breast cancer patients
Glutamine metabolism as a potential biomarker and target for cancer radiosensitization
Harnessing tumor angiogenesis to explore ovarian cancer immune suppression and address target-therapies outcomes
Validation and characterization of monoclonal antibodies to target cancer stem cells and to develop new anti-cancer therapies
Mutational signatures of genotoxic cancer therapies
IL-22 in lavage as a biomarker in patients with lung cancer
IL-22 in lavage as a biomarker in patients with lung cancer
Functional outcomes after local salvage therapies for radiation-recurrent prostate cancer patients: a systematic review
Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies
Adjuvant therapies of cancer
Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients
Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients
Update breast cancer 2020 part 5: moving therapies from advanced to early breast cancer patients
Glutamine metabolism as a potential biomarker and target for cancer radiosensitization
Harnessing tumor angiogenesis to explore ovarian cancer immune suppression and address target-therapies outcomes
Validation and characterization of monoclonal antibodies to target cancer stem cells and to develop new anti-cancer therapies
Mutational signatures of genotoxic cancer therapies
IL-22 in lavage as a biomarker in patients with lung cancer
IL-22 in lavage as a biomarker in patients with lung cancer
Functional outcomes after local salvage therapies for radiation-recurrent prostate cancer patients: a systematic review
Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies
Adjuvant therapies of cancer
Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients
Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients
Update breast cancer 2020 part 5: moving therapies from advanced to early breast cancer patients
Glutamine metabolism as a potential biomarker and target for cancer radiosensitization
Harnessing tumor angiogenesis to explore ovarian cancer immune suppression and address target-therapies outcomes
Validation and characterization of monoclonal antibodies to target cancer stem cells and to develop new anti-cancer therapies
Mutational signatures of genotoxic cancer therapies
IL-22 in lavage as a biomarker in patients with lung cancer
IL-22 in lavage as a biomarker in patients with lung cancer